Broadcrest Asset Management, LLC Enovis Corp Transaction History

Broadcrest Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	SELL	$52.7 - $64.12 $5.27 Million - $6.41 Million	-100,000 Reduced 28.57%	250,000 $16 Million
Q1 2023 May 12, 2023	BUY	$49.5 - $65.92 $2.48 Million - $3.3 Million	50,000 Added 16.67%	350,000 $18.7 Million
Q4 2022 Feb 07, 2023	BUY	$44.83 - $57.43 $2.24 Million - $2.87 Million	50,000 Added 20.0%	300,000 $16.1 Million
Q3 2022 Nov 07, 2022	BUY	$46.07 - $60.1 $2.3 Million - $3.01 Million	50,000 Added 25.0%	250,000 $11.5 Million
Q2 2022 Aug 16, 2022	BUY	$55.0 - $70.47 $11 Million - $14.1 Million	200,000 New	200,000 $11 Million

310

60.2M

1.68M

693K

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $2.38B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

Get notified when there are updates to the investment portfolio of Broadcrest Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Broadcrest Asset Management, LLC with notifications on news.